Generic Parkinson's drug passes first test in healthy volunteers
NCT ID NCT07519278
First seen Apr 10, 2026 · Last updated May 14, 2026 · Updated 6 times
Summary
This study tested whether a new generic version of pramipexole extended-release tablets works the same as the brand-name drug (MIRAPEX ER). It involved 49 healthy Chinese adults who took a single dose of each version under fasting and fed conditions. The goal was to check if the generic drug is absorbed similarly, which is a key step for approval.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The General Hospital of Western Theater Command PLA
Chengdu, Sichuan, China
Conditions
Explore the condition pages connected to this study.